Skip to search formSkip to main contentSkip to account menu

AGM 1470

Known as: AGM-1470 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Semakin banyaknya merek-merek baru yang bermunculan, membuat persaingan merek semakin sengit. Hal ini memaksa setiap perusahaan… 
2007
2007
We studied the expression of angiogenic factors (vascular endothelial growth factor, basic fibroblast growth factor, platelet… 
2006
2006
The biotransformation of O-(chloroacetyl-carbamoyl) fumagillol (TNP470; At .M 1470), a potent in vitro inhibitor of angiogenesis… 
2002
2002
ZusammenfassungAngiogenese spielt beim Tumorwachstum und der Metastasierung einer Vielzahl von malignen Tumoren eine wichtige… 
1999
1999
The efficacy of cis-diammine dichloroplatinum (CDDP) therapy in combination with continuous administration of angiogenesis… 
1997
1997
,, , , , , , , The efficacy of combination therapy with cis-diammine-dichloroplatinum (II) (CDDP) and o-(chloroacetyl-carbamoyl… 
1995
1995
Administration of TNP-470 (AGM-1470), a newly developed angiogenesis inhibitor, elevated serum copper concentrations (SCu) in a…